Regor Therapeutics’ $90 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised Lilly Asia Ventures on the deal.Regor Therapeutics, a clinical-stage biotechnology company dedicated to the discovery of innovative medicines to treat…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here